查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941153

药用洗髮精市场－全球产业规模、份额、趋势、机会及预测（依产品类型、销售管道、地区及竞争格局划分，2021-2031年）

Medicated Shampoo Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Sales Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球药用洗髮精市场预计将从 2025 年的 267.5 亿美元成长到 2031 年的 366.1 亿美元，复合年增长率为 5.37%。

此细分市场主要指含有活性成分的治疗性护髮配方，这些活性成分专门用于治疗头皮屑、干癣和脂漏性皮肤炎等头皮问题。推动市场成长的关键因素包括头皮问题日益增多以及消费者在具有特定健康功效的功能性个人保健产品上的支出不断增长。根据欧洲化妆品协会（Cosmetics Europe）的数据，预计到2024年，欧洲护髮类别的零售额将达到181亿欧元，凸显了市场对头皮和头髮护理解决方案的巨大经济需求。这一强劲表现表明，消费者正强烈转向那些除了基本清洁之外，还能提供经证实有效的治疗功效的产品。

市场概览
预测期 2027-2031
市场规模：2025年 267.5亿美元
市场规模：2031年 366.1亿美元
复合年增长率：2026-2031年 5.37%
成长最快的细分市场 在线的
最大的市场 北美洲

然而，由于对医疗功效和活性成分核准的严格监管，市场扩张面临许多障碍。製造商必须进行严苛的临床试验和安全性检验以证明疗效，这导致营运成本高且研发週期漫长。这种复杂的合规环境提高了市场进入门槛，并限制了新治疗方法在全球推广的速度。

市场驱动因素

慢性头皮疾病（如头皮屑、干癣和脂漏性皮肤炎）的日益普遍是推动全球药用洗髮精市场扩张的主要因素。由于生活方式的改变和环境压力，这些疾病影响全球越来越多的人口，因此，含有活性药物成分的治疗性护髮配方需求显着增加。日益加重的疾病负担迫使消费者从普通洗髮精转向功能性治疗产品，以控制诸如鳞屑和发炎等症状。根据美国国家银屑病基金会2024年8月发布的《银屑病健康指数报告》，美国约有750万成年人（约占成年人口的3%）患有银屑病，证实了专业治疗方案的巨大市场潜力。

同时，皮肤科医生推荐和临床处方笺的快速增长，使得准药物护髮产品从可有可无的卫生用品跃升为必不可少的健康维护品。製造商正透过严格的测试来加强产品检验，以获得医疗核准，这显着影响消费者的购买决策。这种「医疗化」趋势使得拥有可靠临床记录的品牌能够实现高于整体市场的成长速度。例如，欧莱雅于2024年2月发布的2023年度报告指出，其皮肤科和美容部门的同店销售额增长了28.4%，这主要得益于消费者对专家推荐处方的需求。同样，宝洁公司报告称，其护髮部门在2024年实现了接近两位数的有机销售额增长，这主要得益于高级产品和功效型产品组合的良好表现。

市场挑战

严格的活性成分核准和医疗声明监管框架对全球准药品洗髮精市场的成长构成重大障碍。製造商必须进行复杂的临床试验和安全性检验，以证明治疗配方的有效性。这项严苛的流程不可避免地增加了营运成本，并显着延长了研发週期，使企业无法快速回应不断变化的消费者需求。因此，合规带来的经济负担抑制了对新活性成分的投资，阻碍了可能推动市场广泛接受的创新治疗方法的推出。

这种高合规性环境显着提高了准入门槛，尤其对于往往缺乏足够资金储备来应对漫长核准流程的中小型企业而言更是如此。考虑到产业的组成，这种情况尤其严峻：根据欧洲化妆品协会（Cosmetics Europe）统计，截至2024年，欧洲个人护理行业由超过9600家中小企业组成。如此众多的小规模市场参与企业极易受到监管压力的影响，这限制了它们推出小众护理产品的能力，最终导致全球消费者可选择的解决方案种类有限，并阻碍了整体市场扩张。

市场趋势

全球药用洗髮精市场正因微生物友善和益生菌产品的兴起而重塑。产品研发的重点正从简单的病原体清除转向管理头皮的整个生态系统。製造商越来越重视保护角质层和平衡头皮天然菌丛的配方，而不是仅仅使用刺激性活性成分来消除细菌和真菌。这种科学演进与「护髮护肤」的概念相契合，后者利用传统用于脸部护肤的成分，例如益生元和尿素，来修復头皮屏障。这种对皮肤科功效的关注正在带来显着的商业性成果。根据拜尔斯道夫股份公司于2025年2月发布的2024年度报告，该公司旗下包括丝胺酸品牌在内的皮肤护理部门实现了10.6%的有机销售增长，证实了消费者对具有科学先进性的屏障支持护理产品的需求日益增长。

同时，多功能护理产品的开发正在加速优质化，因为消费者越来越倾向在追求头皮健康的同时，也注重秀髮的美观。市场正见证药用效用与美容美感的融合。全新配方在解决潜在问题的同时，也能带来沙龙级的丰盈、护色和改善髮质等效果。这一趋势打破了以往临床洗髮精的刺激性和普通护髮产品的美容效果之间的权衡，从而推动了产品的持续使用和高端定价。根据联合利华公司于2025年2月发布的“2024财年全年业绩报告”，其美容与健康事业部实现了6.5%的销售额增长。这主要得益于其核心产品组合的成功优质化，其中包括将健康功效与卓越美容效果相结合的全新头皮护理产品。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球药用洗髮精市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（头皮屑/脂漏性皮肤炎、干癣、其他）
    • 依销售管道（超级市场/大卖场、药局/药局、百货公司、线上、其他（直销等））
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美药用洗髮精市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲药用洗髮精市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章 亚太地区药用洗髮精市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲药用洗髮精市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲药用洗髮精市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球药用洗髮精市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Procter & Gamble
  • Johnson & Johnson
  • Himalaya Herbal Healthcare
  • Farnam Companies, Inc.
  • Sanofi-Aventis Groupe
  • Summers Laboratories Inc.
  • Maruho Co. Ltd.
  • Kao Corporation
  • Coty Inc.
  • Avalon Natural Products, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 16343

The Global Medicated Shampoo Market is projected to expand from USD 26.75 Billion in 2025 to USD 36.61 Billion by 2031, registering a CAGR of 5.37%. This industry segment is defined by therapeutic hair care formulations containing active agents specifically engineered to treat scalp pathologies such as dandruff, psoriasis, and seborrheic dermatitis. Key drivers propelling market growth include the increasing prevalence of scalp ailments and rising consumer spending on functional personal care products that provide specific health advantages. Data from Cosmetics Europe indicates that the European hair care category generated retail sales of €18.1 billion in 2024, highlighting the substantial economic demand for solutions addressing scalp and hair maintenance. This robust performance signals a strong consumer shift toward products that deliver proven therapeutic results beyond basic hygiene.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 26.75 Billion
Market Size 2031USD 36.61 Billion
CAGR 2026-20315.37%
Fastest Growing SegmentOnline
Largest MarketNorth America

However, market expansion faces a significant hurdle due to the stringent regulatory framework governing the approval of medical claims and active ingredients. Manufacturers are required to navigate rigorous clinical testing and safety validations to substantiate efficacy, resulting in high operational costs and extended development timelines. This complex compliance environment creates high barriers to entry and limits the speed at which new treatments can be introduced to the global consumer base.

Market Driver

The growing prevalence of chronic scalp ailments, such as dandruff, psoriasis, and seborrheic dermatitis, acts as the primary catalyst for the expansion of the Global Medicated Shampoo Market. As these conditions affect a larger portion of the global population due to lifestyle changes and environmental stressors, there is a critical need for therapeutic hair care formulations containing active pharmaceutical ingredients. This rising disease burden compels consumers to switch from cosmetic shampoos to functional treatments designed to manage symptoms like desquamation and inflammation. According to the National Psoriasis Foundation's 'Psoriasis Health Indicator Report' from August 2024, approximately 7.5 million adults in the United States, or about 3% of the adult population, are affected by psoriasis, underscoring the significant addressable market for specialized management solutions.

Concurrently, a surge in dermatologist recommendations and clinical prescriptions is elevating medicated hair care from optional hygiene to essential health maintenance. Manufacturers are increasingly validating their products through rigorous testing to secure medical endorsements, which significantly influences consumer purchasing decisions. This trend toward "medicalization" allows brands with strong clinical heritage to outperform the broader market. For instance, L'Oreal's '2023 Annual Report' released in February 2024 noted that its Dermatological Beauty division achieved 28.4% like-for-like sales growth, driven by demand for expert-recommended formulations. Similarly, Procter & Gamble reported high single-digit organic sales growth in its Hair Care segment in 2024, fueled by a favorable mix of premium and performance-centric products.

Market Challenge

The stringent regulatory framework controlling the approval of active ingredients and medical claims acts as a major impediment to the growth of the Global Medicated Shampoo Market. Manufacturers must navigate complex clinical testing and safety validations to prove the efficacy of their therapeutic formulations. This rigorous process inevitably results in inflated operational costs and significantly prolonged development timelines, preventing companies from swiftly responding to emerging consumer needs. Consequently, the financial burden associated with compliance discourages investment in novel active agents, thereby stalling the introduction of innovative treatments that could drive broader market adoption.

This high-compliance environment establishes formidable barriers to entry, particularly for smaller entities that often lack the capital reserves to sustain extended approval phases. This dynamic is especially critical given the industry's composition; according to Cosmetics Europe, the European personal care industry comprised more than 9,600 small and medium-sized enterprises (SMEs) in 2024. The vulnerability of such a large volume of smaller market participants to these regulatory pressures restricts their ability to launch niche therapeutic products, ultimately limiting the diversity of solutions available to the global consumer base and hampering overall market expansion.

Market Trends

The Global Medicated Shampoo Market is being reshaped by the emergence of microbiome-friendly and probiotic infusions, shifting product development from simple pathogen eradication to holistic scalp ecosystem management. Manufacturers are increasingly prioritizing formulations that preserve the stratum corneum and balance the scalp's natural flora, rather than solely stripping away bacteria or fungi with harsh active agents. This scientific evolution aligns with the "skinification" of hair care, utilizing ingredients traditionally found in facial skincare, such as prebiotics and urea, to repair the scalp barrier. This focus on dermatological efficacy is yielding significant commercial returns; according to Beiersdorf AG's 'Annual Report 2024' from February 2025, the company's Derma business unit, which houses the Eucerin brand, achieved organic sales growth of 10.6%, validating rising consumer demand for scientifically advanced, barrier-supporting care.

Simultaneously, the development of multi-functional therapeutic products is driving premiumization as consumers refuse to compromise on hair aesthetics for the sake of scalp health. The market is witnessing a convergence of medicinal utility and cosmetic elegance, where new formulations are designed to treat underlying pathologies while delivering salon-grade benefits such as volumizing, color protection, and texture enhancement. This trend addresses the historical trade-off between the unpleasant sensory attributes of clinical shampoos and the beautifying effects of standard hair care, encouraging consistent usage and higher price points. According to Unilever PLC's 'Full Year 2024 Results' released in February 2025, the Beauty & Wellbeing division reported underlying sales growth of 6.5%, attributed to the successful premiumization of core portfolios including new scalp-focused innovations that combine health benefits with superior cosmetic results.

Key Market Players

  • Procter & Gamble
  • Johnson & Johnson
  • Himalaya Herbal Healthcare
  • Farnam Companies, Inc.
  • Sanofi-Aventis Groupe
  • Summers Laboratories Inc.
  • Maruho Co. Ltd.
  • Kao Corporation
  • Coty Inc.
  • Avalon Natural Products, Inc.

Report Scope

In this report, the Global Medicated Shampoo Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medicated Shampoo Market, By Product Type

  • Dandruff & Seborrheic Dermatitis
  • Psoriasis
  • Others

Medicated Shampoo Market, By Sales Channel

  • Supermarkets/Hypermarkets
  • Pharmacy & Drug Stores
  • Departmental Stores
  • Online
  • Others (Direct Sales etc.)

Medicated Shampoo Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medicated Shampoo Market.

Available Customizations:

Global Medicated Shampoo Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medicated Shampoo Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Dandruff & Seborrheic Dermatitis, Psoriasis, Others)
    • 5.2.2. By Sales Channel (Supermarkets/Hypermarkets, Pharmacy & Drug Stores, Departmental Stores, Online, Others (Direct Sales etc.))
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Medicated Shampoo Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medicated Shampoo Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Canada Medicated Shampoo Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Mexico Medicated Shampoo Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Sales Channel

7. Europe Medicated Shampoo Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medicated Shampoo Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. France Medicated Shampoo Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Medicated Shampoo Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Medicated Shampoo Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Medicated Shampoo Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Sales Channel

8. Asia Pacific Medicated Shampoo Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Medicated Shampoo Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Medicated Shampoo Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. Japan Medicated Shampoo Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. South Korea Medicated Shampoo Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Medicated Shampoo Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Sales Channel

9. Middle East & Africa Medicated Shampoo Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Medicated Shampoo Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. UAE Medicated Shampoo Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. South Africa Medicated Shampoo Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Sales Channel

10. South America Medicated Shampoo Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medicated Shampoo Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Colombia Medicated Shampoo Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. Argentina Medicated Shampoo Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Medicated Shampoo Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Procter & Gamble
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Johnson & Johnson
  • 15.3. Himalaya Herbal Healthcare
  • 15.4. Farnam Companies, Inc.
  • 15.5. Sanofi-Aventis Groupe
  • 15.6. Summers Laboratories Inc.
  • 15.7. Maruho Co. Ltd.
  • 15.8. Kao Corporation
  • 15.9. Coty Inc.
  • 15.10. Avalon Natural Products, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer